You are here: Home » News-CM » Companies » Results
Business Standard

Sun Pharmaceuticals Industries reports standalone net loss of Rs 1290.99 crore in the June 2017 quarter

Capital Market 

Sales decline 0.27% to Rs 1733.97 crore

Net Loss of Sun Pharmaceuticals Industries reported to Rs 1290.99 crore in the quarter ended June 2017 as against net loss of Rs 151.46 crore during the previous quarter ended June 2016. Sales declined 0.27% to Rs 1733.97 crore in the quarter ended June 2017 as against Rs 1738.58 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales1733.971738.58 0 OPM %-9.97-3.91 -PBDT-230.46-43.01 -436 PBT-339.23-148.01 -129 NP-1290.99-151.46 -752

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU